NVO - Alnylam Lilly AstraZeneca among best performing pharmas biotechs in Q2 June, 30 2024 08:30 PM Novo Nordisk A/S 2024-06-30 20:30:56 ET Rounding out the top five were Moderna ( NASDAQ: MRNA ) and Novo Nordisk ( NVO ) with gains of, respectively, ~12.5% and ~11.9% .... For further details see: Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2